KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Inventory (2016 - 2025)

Pacific Biosciences Of California has reported Inventory over the past 16 years, most recently at $49.3 million for Q4 2025.

  • Quarterly results put Inventory at $49.3 million for Q4 2025, down 16.12% from a year ago — trailing twelve months through Dec 2025 was $49.3 million (down 16.12% YoY), and the annual figure for FY2025 was $49.3 million, down 16.12%.
  • Inventory for Q4 2025 was $49.3 million at Pacific Biosciences Of California, down from $53.2 million in the prior quarter.
  • Over the last five years, Inventory for PACB hit a ceiling of $68.6 million in Q2 2024 and a floor of $16.3 million in Q1 2021.
  • Median Inventory over the past 5 years was $53.8 million (2025), compared with a mean of $49.7 million.
  • Biggest five-year swings in Inventory: surged 109.13% in 2023 and later dropped 21.51% in 2025.
  • Pacific Biosciences Of California's Inventory stood at $24.6 million in 2021, then skyrocketed by 104.81% to $50.4 million in 2022, then grew by 12.49% to $56.7 million in 2023, then grew by 3.67% to $58.8 million in 2024, then fell by 16.12% to $49.3 million in 2025.
  • The last three reported values for Inventory were $49.3 million (Q4 2025), $53.2 million (Q3 2025), and $53.8 million (Q2 2025) per Business Quant data.